Plunkett Research Online: Pacira Pharmaceuticals Inc

PACIRA PHARMACEUTICALS INC (PCRX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products. Its products are based on the proprietary DepoFoam drug delivery technology and intended for use in hospitals and ambula.....



Pacira Pharmaceuticals Inc
Ticker: PCRX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 973-254-3560
Fax:
Address: 5 Sylvan Way
Suite 300
Parsippany, NJ 07054 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
David StackCEO/Director/Chairman of the Board
Charles ReinhartCFO
See More
Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products. Its products are based on the proprietary DepoFoam drug delivery technology and intended for use in hospitals and ambula.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
DepoFoam
EXPAREL
DepoCyt
DepoMeloxicam
DepoTranexamic Acid
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: